ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 40590448.
- Also identified by DOI 10.1097/ADM.0000000000001494 and PMC identifier 13225189.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This commentary highlights significant research gaps identified during the creation of the ASAM/AAAP Clinical Practice Guideline (CPG) on the Management of Stimulant Use Disorder (StUD). These included further research into the implementation of contingency management for StUD, pharmacotherapy options for StUD, evaluation and treatment of stimulant-induced psychosis, harm reduction techniques, and better defining a stimulant overdose. Further research concerning other populations impacted by stimulant use, including adolescents, pregnant and incarcerated individuals, and minoritized populations, is also urgently needed.
Medical subject headings
- Central Nervous System Stimulants
- Practice Guidelines as Topic
- Substance-Related Disorders